当前位置:首页 - 行情中心 - 华熙生物(688363) - 财务分析 - 现金流量表

华熙生物

(688363)

  

流通市值:159.72亿  总市值:159.72亿
流通股本:4.82亿   总股本:4.82亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,030,952,619.872,125,782,095.89887,508,516.44,430,650,311.4
  收到的税费返还27,805,782.1617,662,635.1815,053,824.3528,084,322.57
  收到其他与经营活动有关的现金85,809,610.8233,530,072.1243,548,482.59241,717,904.3
  经营活动现金流入小计3,144,568,012.852,176,974,803.19946,110,823.344,700,452,538.27
  购买商品、接受劳务支付的现金710,700,778.65382,751,567.75132,655,292.061,071,202,392.66
  支付给职工以及为职工支付的现金725,857,213.69485,066,999.25215,295,501.531,155,171,930.08
  支付的各项税费187,264,808.6136,512,272.474,741,052.58254,128,635.22
  支付其他与经营活动有关的现金941,346,264.67648,470,007.02392,458,966.491,592,499,647.99
  经营活动现金流出小计2,565,169,065.611,652,800,846.42815,150,812.664,073,002,605.95
  经营活动产生的现金流量净额579,398,947.24524,173,956.77130,960,010.68627,449,932.32
二、投资活动产生的现金流量:
  收回投资收到的现金8,485,752.468,574,429.42-128,966.58
  取得投资收益收到的现金5,303,701.182,856,555.041,005,657.2410,422,604.9
  处置固定资产、无形资产和其他长期资产收回的现金净额334,235.72276,215.724,471.12,073,945.55
  收到的其他与投资活动有关的现金769,861,559.6512,971,778416,456,100451,000,000
  投资活动现金流入小计783,985,248.96524,678,978.18417,466,228.34463,625,517.03
  购建固定资产、无形资产和其他长期资产支付的现金267,694,185.42173,481,289.28101,522,084.12325,677,846.28
  投资支付的现金145,941,867.9140,981,603.3913,500,00068,853,353.81
  支付其他与投资活动有关的现金932,822,490.8783,838,100.55446,456,100333,960,000
  投资活动现金流出小计1,346,458,544.121,098,300,993.22561,478,184.12728,491,200.09
  投资活动产生的现金流量净额-562,473,295.16-573,622,015.04-144,011,955.78-264,865,683.06
三、筹资活动产生的现金流量:
  吸收投资收到的现金5,880,0004,200,000-2,520,000
  其中:子公司吸收少数股东投资收到的现金5,880,0004,200,000-2,520,000
  取得借款收到的现金147,057,166.6667,057,166.6666,665,000310,280,683.61
  筹资活动现金流入小计152,937,166.6671,257,166.6666,665,000312,800,683.61
  偿还债务支付的现金182,806,125.04125,810,885.8324,077,596.57202,629,200.48
  分配股利、利润或偿付利息支付的现金95,423,064.322,748,335.911,315,165.6156,078,754.56
  支付其他与筹资活动有关的现金37,612,321.9826,155,439.966,626,678.4356,392,125.26
  筹资活动现金流出小计315,841,511.34154,714,661.732,019,440.61315,100,080.3
  筹资活动产生的现金流量净额-162,904,344.68-83,457,495.0434,645,559.39-2,299,396.69
四、汇率变动对现金及现金等价物的影响-22,679,495.29-16,719,149.77-8,475,867.363,998,656.12
五、现金及现金等价物净增加额-168,658,187.89-149,624,703.0813,117,746.93364,283,508.69
  加:期初现金及现金等价物余额977,775,917.06977,775,917.06977,775,917.06613,492,408.37
  期末现金及现金等价物余额809,117,729.17828,151,213.98990,893,663.99977,775,917.06
补充资料:
  净利润-153,164,597.52-291,148,370.39
  资产减值准备-10,501,507.41-108,053,142.71
  固定资产和投资性房地产折旧-158,773,934.81-282,926,828.17
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-158,773,934.81-282,926,828.17
  无形资产摊销-14,459,595.47-27,260,609.23
  长期待摊费用摊销-17,664,674.54-33,176,989.05
  处置固定资产、无形资产和其他长期资产的损失--594,407.25--217,334.91
  固定资产报废损失-72,276.08-2,160,447.35
  公允价值变动损失--1,884,667.39--19,623,286.8
  财务费用-21,572,311.45-2,418,325.03
  投资损失--23,257,825.62-5,471,394.65
  递延所得税--15,066,444.14-19,678,789.89
  其中:递延所得税资产减少--13,835,577.97-20,003,609.71
    递延所得税负债增加--1,230,866.17--324,819.82
  存货的减少-89,001,883.13-162,150,697.82
  经营性应收项目的减少-26,370,499.63--38,988,841.48
  经营性应付项目的增加-46,747,116.95--327,967,578.94
  其他----5,283,388.57
  不涉及现金收支的投资和筹资活动金额其他项目-28,432,711.95-41,489,473.44
  现金的期末余额-828,151,213.98-977,775,917.06
  减:现金的期初余额-977,775,917.06-613,492,408.37
  现金及现金等价物的净增加额--149,624,703.08-364,283,508.69
公告日期2026-10-302026-08-282026-04-302026-04-23
审计意见(境内)标准无保留意见
TOP↑